Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis von Kragt, J J, van der Linden, F AH, Nielsen, J M, Uitdehaag, B MJ, Polman, C H

Volltext

Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use von van der Linden, F A H, Kragt, J J, Klein, M, van der Ploeg, H M, Polman, C H, Uitdehaag, B M J

Volltext

Proxy measurements in multiple sclerosis: agreement on different patient-reported outcome scales von Sonder, JM, Bosma, LVAE, van der Linden, FAH, Knol, DL, Polman, CH, Uitdehaag, BMJ

Volltext

Disease progression in multiple sclerosis: combining physicians’ and patients’ perspectives? von Kragt, JJ, Nielsen, JM, van der Linden, FAH, Polman, CH, Uitdehaag, BMJ

Volltext

Proxy ratings from multiple sources: disagreement on the impact of multiple sclerosis on daily life von Van Der Linden, F. A. H., D'hooghe, M. B., Nagels, G., Van Nunen, A., Polman, C. H., Uitdehaag, B. M. J.

Volltext

How similar are commonly combined criteria for EDSS progression in multiple sclerosis? von Kragt, J J, Nielsen, J M, van der Linden, F AH, Uitdehaag, B MJ, Polman, C H

Volltext

Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis von Kragt, J J, van der Linden, FAH, Nielsen, J M, Uitdehaag, BMJ, Polman, CH

Volltext

The size of the treatment effect: do patients and proxies agree? von van der Linden, FAH, Kragt, JJ, Hobart, JC, Klein, M, Thompson, AJ, van der Ploeg, HM, Polman, CH, Uitdehaag, BMJ

Volltext bestellen

Longitudinal proxy measurements in multiple sclerosis: patient-proxy agreement on the impact of MS on daily life over a period of two years von van der Linden, FAH, Kragt, JJ, van Bon, M, Klein, M, Thompson, AJ, van der Ploeg, HM, Polman, CH, Uitdehaag, BMJ

Volltext bestellen